We used the tumor cell line TC-1, a lung epithelial cell line, because we previously showed that TC-1 cells expresses PD-L1 and exploit this mechanism to counteract effector T cells that express high levels of PD-1 [49]. This evidence concerns the gene CD274 and neoplasm.